Article info
PDFMultiple sclerosis
Short report
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis
- Correspondence to Dr Zoé L E van Kempen, Neurology, Amsterdam UMC - Locatie VUMC, Amsterdam 1081 HV, The Netherlands; Z.vankempen{at}amsterdamumc.nl
Citation
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis
Publication history
- Received August 3, 2022
- Accepted November 6, 2022
- First published December 23, 2022.
Online issue publication
May 17, 2023
Article Versions
- Previous version (14 March 2023).
- Previous version (27 April 2023).
- Previous version (27 April 2023).
- Previous version (27 April 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.